ArticleIJU case reports2026

A Case of a Durable Partial Response to Late-Line Axitinib Following Prior Use of Tyrosine Kinase Inhibitors in Metastatic Papillary Renal Cell Carcinoma.

Naoto Hodotsuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.